Model-informed COVID-19 vaccine prioritization strategies by age and serostatus
Journal Article
Overview
publication date
- February 26, 2021
has subject area
- Adolescent
- Adult
- Aged
- Blood Proteins - Antibodies, Viral
- COVID-19 Vaccines
- Child
- Communicable Disease Control - Mass Vaccination
- Coronavirus Infections - COVID-19
- Environment and Public Health - Age Factors
- Environment and Public Health - Seroepidemiologic Studies
- Globulins - Antibodies, Viral
- Health Care Economics and Organizations - Health Priorities
- Health Care Evaluation Mechanisms - Seroepidemiologic Studies
- Health Care Quality, Access, and Evaluation - Age Factors
- Health Care Quality, Access, and Evaluation - Health Priorities
- Humans
- Immunization Programs - Mass Vaccination
- Immunogenicity, Vaccine
- Immunologic Techniques - Mass Vaccination
- Immunoproteins - Antibodies, Viral
- Immunotherapy - Mass Vaccination
- Infections - COVID-19
- Infections - COVID-19
- Investigative Techniques - Seroepidemiologic Studies
- Lung Diseases - COVID-19
- Middle Aged
- Models, Theoretical
- Preventive Health Services - Mass Vaccination
- Public Health Practice - Mass Vaccination
- Respiratory Tract Diseases - COVID-19
- Respiratory Tract Diseases - COVID-19
- SARS-CoV-2
- Virus Diseases - COVID-19
- Young Adult
has restriction
- hybrid
Date in CU Experts
- January 24, 2021 3:20 AM
Full Author List
- Bubar KM; Reinholt K; Kissler SM; Lipsitch M; Cobey S; Grad YH; Larremore DB
author count
- 7
citation count
- 483
published in
- Science Journal
Other Profiles
International Standard Serial Number (ISSN)
- 0036-8075
Electronic International Standard Serial Number (EISSN)
- 1095-9203
Digital Object Identifier (DOI)
Additional Document Info
start page
- 916
end page
- +
volume
- 371
issue
- 6532